Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal Cancer

Authors:

Abstract
No abstract available
Funding Information
  • Eisai Korea Inc

This publication has 25 references indexed in Scilit: